索引于
- 打开 J 门
- Genamics 期刊搜索
- 学术钥匙
- 期刊目录
- 研究圣经
- 电子期刊图书馆
- 参考搜索
- 哈姆达大学
- 亚利桑那州EBSCO
- OCLC-WorldCat
- 普罗奎斯特传票
- SWB 在线目录
- 虚拟生物学图书馆 (vifabio)
- 普布隆斯
- 米亚尔
- 欧洲酒吧
- 谷歌学术
分享此页面
期刊传单
抽象的
Drug discovery at the Institute of Organic Chemistry and Biochemistry �?? past and present
Martin Fusek
The IOCB Prague was incorporated in 1953 as a part of the Czech Academy of Sciences. Already in early seventies first drugs developed by IOCB Prague scientists entered market. These drugs were commercialized through collaboration with local pharmaceutical company SPOFA and later with company Ferring. Great success of the research of prof. Antonín Holý brought antiviral drugs which were commercialized in collaboration with KU Leuven and US company Gilead Sciences. These drugs represent one of the main pillars in the treatment of HIV and HBV patients. Over last decade we have signed several license agreements with pharmaceutical companies and currently there are more than 10 projects in a preclinical development running at the IOCB Prague.